CDK6 and renal carcinoma: Meanwhile, it is suggested that miR‐384 inhibits the tumorigenesis of renal cancer through regulating cyclin‐dependent kinase 6,30 which supports our finding that miR‐384 suppresses bladder cancer cell viability.